Development and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin Carcinogenesis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tyagi, Nikhil ^a   Bhardwaj, Arun ^a   Srivastava, Sanjeev K ^a   Arora, Sumit ^a   Marimuthu, Saravanakumar ^a   Deshmukh, Sachin K ^a   Singh, Ajay P ^a   Carter, James E ^b   Singh, Seema ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECTS; ANIMAL; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CELL TRANSFORMATION; DISEASE COURSE; DISEASE MODEL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VITRO STUDY; MOUSE; PATHOLOGY; RADIATION RESPONSE; SKIN NEOPLASMS; TUMOR CELL LINE; ULTRAVIOLET RADIATION; XENOGRAFT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HETEROGRAFTS; HUMANS; IN VITRO TECHNIQUES; MICE; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84941031933     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13894     Document Type: Article

References (50)

1. Stern, R. S. Prevalence of a history of skin cancer in 2007: results of an incidence-basedmodel. Arch. Dermatol. 146, 279-282 (2010).
2. Donaldson, M. R., Coldiron, B. M. No end in sight: the skin cancer epidemic continues. Semin. Cutan. Med. Surg. 30, 3-5 (2011).
3. Lomas, A., Leonardi-Bee, J., Bath-Hextall, F. A systematic review of worldwide incidenceof nonmelanoma skin cancer. Br. J. Dermatol. 166, 1069-1080 (2012).
4. Jemal, A. et al. Recent trends in cutaneous melanoma incidence and death rates in theUnited States, 1992-2006. J. Am. Acad. Dermatol. 65, S17-S25 (2011).
5. Robinson, J. K. Sun exposure, sun protection, and vitamin D. JAMA. 294, 1541-1543 (2005).
6. Rogers, H. W. et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch. Dermatol. 146, 283-287 (2010).
7. Guy, G. P., Jr., Machlin, S. R., Ekwueme, D. U., Yabroff, K. R. Prevalence and costs of skin cancer treatment in the U. S., 2002-2006 and 2007-2011. Am. J. Prev. Med. 48, 183-187 (2015).
8. Leiter, U., Garbe, C. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv. Exp. Med. Biol. 624, 89-103 (2008).
9. Leiter, U., Eigentler, T., Garbe, C. Epidemiology of skin cancer. Adv. Exp. Med. Biol. 810, 120-140 (2014).
10. Matsui, M. S., DeLeo, V. A. Longwave ultraviolet radiation and promotion of skin cancer. Cancer Cells. 3, 8-12 (1991).
11. Bowden, G. T. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat. Rev. Cancer. 4, 23-35 (2004).
12. Ikehata, H., Ono, T. The mechanisms of UV mutagenesis. J. Radiat. Res. 52, 115-125 (2011).
13. Rastogi, R. P., Richa Kumar, A., Tyagi, M. B., Sinha, R. P. Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J. Nucleic Acids. 2010, 592980 (2010).
14. Ziegler, A. et al. Sunburn and p53 in the onset of skin cancer. Nature. 372, 773-776 (1994).
15. Satyanarayana, A., Kaldis, P. Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene. 28, 2925-2939 (2009).
16. Kastan, M. B., Bartek, J. Cell-cycle checkpoints and cancer. Nature. 432, 316-323 (2004).
17. Lamouille, S., Xu, J., Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178-196 (2014).
18. Shankar, J. et al. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res. 70, 3780-3790 (2010).
19. Boukamp, P., Stanbridge, E. J., Foo, D. Y., Cerutti, P. A., Fusenig, N. E. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res. 50, 2840-2847 (1990).
20. Boukamp, P. et al. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene. 18, 5638-5645 (1999).
21. Ren, Q. et al. Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling. Cancer Res. 66, 5209-5215 (2006).
22. D'Orazio, J., Jarrett, S., Amaro-Ortiz, A., Scott, T. UV Radiation and the Skin. Int. J. Mol. Sci. 14, 12222-12248 (2013).
23. Syed, D. N., Afaq, F., Mukhtar, H. Differential activation of signaling pathways by UVA and UVB radiation in normal human epidermal keratinocytes. Photochem. Photobiol. 88, 1184-1190 (2012).
24. Autier, P. et al. Sunscreen use and duration of sun exposure: a double-blind, randomized trial. J. Natl. Cancer Inst. 91, 1304-1309 (1999).
25. Geller, A. C. et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics. 109, 1009-1014 (2002).
26. Boukamp, P. et al. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes. Cancer. 19, 201-214 (1997).
27. Lisby, S., Gniadecki, R., Wulf, H. C. UV-induced DNA damage in human keratinocytes: quantitation and correlation with long-term survival. Exp. Dermatol. 14, 349-355 (2005).
28. Arora, S. et al. Silver nanoparticles protect human keratinocytes against UVB radiation-induced DNA damage and apoptosis: potential for prevention of skin carcinogenesis. Nanomedicine. 11, 1265-75 (2015).
29. He, Y. Y. et al. Chronic UVA irradiation of human HaCaT keratinocytes induces malignant transformation associated with acquired apoptotic resistance. Oncogene. 25, 3680-3688 (2006).
30. Han, W., He, Y. Y. Requirement for metalloproteinase-dependent ERK and AKT activation in UVB-induced G1-S cell cycle progression of human keratinocytes. Photochem. Photobiol. 85, 997-1003 (2009).
31. Reagan-Shaw, S., Breur, J., Ahmad, N. Enhancement of UVB radiation-mediated apoptosis by sanguinarine in HaCaT human immortalized keratinocytes. Mol. Cancer Ther. 5, 418-429 (2006).
32. Carr, T. D., DiGiovanni, J., Lynch, C. J., Shantz, L. M. Inhibition of mTOR suppresses UVB-induced keratinocyte proliferation and survival. Cancer Prev. Res. (Phila). 5, 1394-1404 (2012).
33. Nomura, M. et al. Mitogen-and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation. J. Biol. Chem. 276, 25558-25567 (2001).
34. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 35, 495-516 (2007).
35. Liang, S. B. et al. Overexpression of cyclin D1 in nonmelanocytic skin cancer. Virchows Arch. 436, 370-376 (2000).
36. Delehedde, M. et al. Altered expression of bcl-2 family member proteins in nonmelanoma skin cancer. Cancer. 85, 1514-1522 (1999).
37. Singh, A., Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751 (2010).
38. Hung, C. F., Chiang, H. S., Lo, H. M., Jian, J. S., Wu, W. B. E-cadherin and its downstream catenins are proteolytically cleaved in human HaCaT keratinocytes exposed to UVB. Exp. Dermatol. 15, 315-321 (2006).
39. Hudson, L. G. et al. Ultraviolet radiation stimulates expression of Snail family transcription factors in keratinocytes. Mol. Carcinog. 46, 257-268 (2007).
40. Newkirk, K. M. et al. Snai2 expression enhances ultraviolet radiation-induced skin carcinogenesis. Am. J. Pathol. 171, 1629-1639 (2007).
41. Chaudhary, S. C. et al. Erb-041, an estrogen receptor-beta agonist, inhibits skin photocarcinogenesis in SKH-1 hairless mice by downregulating the WNT signaling pathway. Cancer Prev. Res. (Phila). 7, 186-198 (2014).
42. Skobe, M., Fusenig, N. E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. USA 95, 1050-1055 (1998).
43. Ren, Q. et al. Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling. Cancer Res. 66, 5209-5215 (2006).
44. Masters, J. R. et al. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl. Acad. Sci. USA. 98, 8012-8017 (2001).
45. Tyagi, N. et al. p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT-and ERKdependent activation of NF-kappaB pathway. Oncotarget. 5, 8778-8789 (2014).
46. Srivastava, S. K. et al. Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasis. Br. J. Cancer. 112, 1772-1781 (2015).
47. Bhardwaj, A. et al. CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1. Oncotarget. 5, 11490-11500 (2014).
48. Deshmukh, S. K. et al. Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation. Oncotarget. 10, 11234-11241 (2015).
49. Srivastava, S. K. et al. Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance. Carcinogenesis 33, 1149-1157 (2012).
50. Bhardwaj, A. et al. Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model. Br. J. Cancer. 110, 2000-2010 (2014).